The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 14, 2011
Filed:
Feb. 14, 2007
Arthur G. Taveras, Southborough, MA (US);
Motasim Billah, Edison, NJ (US);
Daniel Lundell, Flemington, NJ (US);
William Kreutner, West Paterson, NJ (US);
James Jakway, Bridgewater, NJ (US);
Jay S. Fine, Bloomfield, NJ (US);
Loretta A. Bober, Linden, NJ (US);
Jianhua Chao, Pompton Lakes, NJ (US);
Purakkattle J. Biju, Piscaraway, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Arthur G. Taveras, Southborough, MA (US);
Motasim Billah, Edison, NJ (US);
Daniel Lundell, Flemington, NJ (US);
William Kreutner, West Paterson, NJ (US);
James Jakway, Bridgewater, NJ (US);
Jay S. Fine, Bloomfield, NJ (US);
Loretta A. Bober, Linden, NJ (US);
Jianhua Chao, Pompton Lakes, NJ (US);
Purakkattle J. Biju, Piscaraway, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Schering Corporation, Kenilworth, NJ (US);
Abstract
Methods of treating chemokine-mediated diseases are disclosed. The methods comprise the administration of CXC-Chemokine receptor antagonists of the formula or pharmaceutically acceptable salts or solvates thereof, in combination with other classes of pharmaceutical compounds. The chemokine-mediated diseases include acute and chronic inflammatory disorders, psoriasis, cystic fibrosis, asthma and cancer. Also disclosed are novel compounds of formula (I).